Public genomics is effectively the public facet of personal genomics.

Dr Scaria has also been involved in popularising personal genomics through meragenome.comand OpenPGx.

As of February 2012, this has only been done for patients clinical trials designed to assess the personal genomics approach to cancer treatment.

He is widely regarded as a pioneer in personal genomics and synthetic biology.

This problem is projected to increase with personal genomics as it will create an even greater accumulation of data.

Researchers in the institute have been pioneering community participation in personal genomics.

In a June 2008 article on personal genomics, a doctor from the Southern Illinois University School of Medicine said:

Biotechnology offers the prospect that in the future, all individuals, even those without known risk factors, will be able to afford a full genome sequence report (see personal genomics).

In addition to the basic scientific breakthroughs that have made these discoveries possible, this field of work has opened up an entire new avenue of business: personal genomics.

But the biochip makers are now chasing a bigger opportunity: personal genomics.